Pharmaceutical Product Supply – Triamcinolone Acetonide Ointment

The contract involves the supply of 10 treatment units of Triamcinolone Acetonide Ointment, strictly aligned with FDA and Department of Defense pharmaceutical standards to ensure safety, efficacy, and regulatory compliance. The product must be packaged and labeled according to military and federal specifications, including proper identification, dosage instructions, expiration dating, and handling requirements suitable for deployment and clinical use in defense medical facilities. The agreement is structured as a subcontract under the Defense Logistics Agency, reflecting its role in supporting DoD healthcare logistics, with the NAICS code 325412 indicating pharmaceutical preparation manufacturing as the primary industry classification. The contract was posted on July 20, 2026, and is linked to active delivery and procurement activity through contract identifiers SPE2DX25D9900 and SPE2DP26F7777, signifying its integration into the DoD’s supply chain for essential pharmaceuticals.